Apogee Therapeutics (APGE) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.22
-1.13
-1.04
-0.95

Details

Expected EPS
-1.175394
Actual EPS
-1.11
Surprise EPS
0.07
Surprise Percent
+5.56%

Description

Apogee Therapeutics (APGE) has reported earnings of -1.11 per share for Q4 2025.

0 Comments

Share your thoughts